Evropska unija - slovenščina - EMA (European Medicines Agency)

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - mačke - za pridobivanje telesne teže pri mačkah slaba apetita in izguba teže, ki je posledica kroničnih obolenj.

Evropska unija - slovenščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - mačke - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. zdravilo je izključno navedeno ko so vse tri skupine, ki so usmerjeni na istem času.

Evropska unija - slovenščina - EMA (European Medicines Agency)

almirall, s.a. - tirbanibulin - keratoza, aktinik - antibiotiki in kemoterapevtiki za dermatološko uporabo - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.

Evropska unija - slovenščina - EMA (European Medicines Agency)

intervet international bv - indoksakarb - ectoparasiticides za lokalno uporabo, vključno. insekticidi, indoksakarb - dogs; cats - zdravljenje in preprečevanje infestacij bolh. za pse in mačke: zdravljenje in preprečevanje infestacij bolh. zdravilo za uporabo v veterinarski medicini se lahko uporablja kot del strategije zdravljenja alergijskega dermatitisa. razvoj stopenj bolh v neposredni okolici hišne živali se uniči po stiku s hišnimi živalmi, ki jih zdravimo z activylom.

Evropska unija - slovenščina - EMA (European Medicines Agency)

galderma international - brimonidin tartrat - kožne bolezni - drugi dermatološki preparati - mirvaso je indiciran za simptomatsko zdravljenje eritem obraza rozacee pri odraslih bolnikih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - priprave za zdravljenje ran in razjed - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.

Evropska unija - slovenščina - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - drugi dermatološki preparati - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Evropska unija - slovenščina - EMA (European Medicines Agency)

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.

Evropska unija - slovenščina - EMA (European Medicines Agency)

astrazeneca ab - fulvestrant - neoplazme dojke - endokrini terapije, anti-estrogene - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. v pre - ali perimenopausal ženske, kombinacija zdravljenja z palbociclib je treba v kombinaciji z luteinizirajoči hormon sproščujoči hormon (lhrh) agonist.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer animal health gmbh -